CYP2D6 and malaria: Experts also suggested eight additional factors to the BAT which were vivax case heterogeneity, severity of G6PD deficiency, safety of radical cure, feasibility of evidence use in policy change, variant type of enzyme CYP2D6 gene, insecticide resistance, quality of malaria commodities, existence of community outreach (S7 Table).